3/24
09:26 am
ovid
Rating for OVID
Medium
Report
Rating for OVID
3/12
10:24 am
ovid
Rating for OVID
Low
Report
Rating for OVID
3/12
10:24 am
ovid
Rating for OVID
Low
Report
Rating for OVID
3/12
09:11 am
ovid
Ovid Therapeutics Inc. (NASDAQ: OVID) had its "outperform" rating re-affirmed by analysts at Wedbush.
Medium
Report
Ovid Therapeutics Inc. (NASDAQ: OVID) had its "outperform" rating re-affirmed by analysts at Wedbush.
3/12
09:11 am
ovid
Ovid Therapeutics Inc. (NASDAQ: OVID) had its "outperform" rating re-affirmed by analysts at Wedbush.
Medium
Report
Ovid Therapeutics Inc. (NASDAQ: OVID) had its "outperform" rating re-affirmed by analysts at Wedbush.
1/29
01:21 pm
ovid
Ovid Therapeutics Inc. (NASDAQ: OVID) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $4.00 price target on the stock.
Low
Report
Ovid Therapeutics Inc. (NASDAQ: OVID) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $4.00 price target on the stock.
1/29
01:03 pm
ovid
Rating for OVID
Low
Report
Rating for OVID
1/29
01:03 pm
ovid
Rating for OVID
Low
Report
Rating for OVID
1/29
09:47 am
ovid
Ovid Therapeutics upgraded to Outperform from Perform at Oppenheimer
Low
Report
Ovid Therapeutics upgraded to Outperform from Perform at Oppenheimer
1/29
09:47 am
ovid
Ovid Therapeutics upgraded to Outperform from Perform at Oppenheimer
Low
Report
Ovid Therapeutics upgraded to Outperform from Perform at Oppenheimer